E2 inhibited EFNA5 expression in the hypothalamus, which further suppressed LH release. In addition, EPHA7-Fc systemic administration appeared to restrain the E2-associated inhibition of Efna5 and Gnrh1, contributing to increased Efna5 and Gnrh1 expression and increased serum LH levels.